Retatrutide is a new treatment in the fight against obesity. This revolutionary drug, classified as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By boosting these receptors, Retatrutide suppresses appetite, {promotesenergy expenditure, and ultimately leads to significant slimming. While studies are stil